Laura Faravelli was appointed VP Business Development on July 1, 2023. Since 2015, Laura has held various management roles in Newron’s business development function.  She has over 20 years of experience in international research, development and regulatory approval of new products for central nervous system indications and in drug repositioning. Laura holds a PhD in Neurobiology and a master’s degree in Regulatory Affairs and Market Access.  Before transitioning to business development, she held management positions in Newron’s R&D unit, including in discovery, pharmacology research and non-clinical development, contributing to successful European Medicines Agency marketing authorisation application (MAA) and US Food and Drug Administration new drug application (NDA) processes. She started her post-academic career at Pharmacia & Upjohn. Laura Faravelli is Italian.